CME/CE: Oral Anticoagulants and Brain Bleeds
By: Alere Staff
June 16, 2015 – June 16, 2017
Physicians: 0.25 AMA PRA Category 1 Credit(s) ™
Restarting oral anticoagulation (OAC) after warfarin-related intracranial hemorrhage (ICH) in non-valvular atrial fibrillation (AF) patients reduces the otherwise elevated risk of ischemic stroke and/or mortality. Stopping antithrombotic treatment following ICH or treating with antiplatelet therapy instead of an oral anticoagulant is riskier than resuming OAC treatment.